202 related articles for article (PubMed ID: 1122488)
1. Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors.
Gutin PH; Wilson CB; Kumar AR; Boldrey EB; Levin V; Powell M; Enot KJ
Cancer; 1975 May; 35(5):1398-404. PubMed ID: 1122488
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
Shapiro WR; Young DF
Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
Heiss WD; Turnheim M; Mamoli B
Eur J Cancer (1965); 1978 Nov; 14(11):1191-202. PubMed ID: 216554
[No Abstract] [Full Text] [Related]
4. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
[TBL] [Abstract][Full Text] [Related]
6. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
Webre C; Shonka N; Smith L; Liu D; De Groot J
Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
[TBL] [Abstract][Full Text] [Related]
7. Nitrosourea chemotherapy for primary malignant gliomas.
Levin VA; Wilson CB
Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors.
Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
Eur J Cancer (1965); 1975 Aug; 11(8):585-7. PubMed ID: 1222765
[No Abstract] [Full Text] [Related]
9. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
10. Single-agent chemotherapy of brain tumors. A five-year review.
Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
[TBL] [Abstract][Full Text] [Related]
11. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Brufman G; Halpern J; Sulkes A; Catane R; Biran S
Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
[TBL] [Abstract][Full Text] [Related]
13. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.
Seiler RW; Greiner RH; Zimmerman A; Markwalder H
J Neurosurg; 1978 Jun; 48(6):861-5. PubMed ID: 77898
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
17. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
[TBL] [Abstract][Full Text] [Related]
18. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
Lassman AB
CNS Oncol; 2015; 4(5):341-6. PubMed ID: 26544062
[TBL] [Abstract][Full Text] [Related]
19. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA
Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900
[TBL] [Abstract][Full Text] [Related]
20. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Van Dyk JJ; Falkson G
Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
